Follow
Abhinav Anand
Abhinav Anand
Lovely Professional University
Verified email at apsecr.org
Title
Cited by
Cited by
Year
The present and future of pharmacotherapy of Alzheimer’s disease: A comprehensive review
A Anand, AA Patience, N Sharma, N Khurana
European journal of pharmacology 815, 364-375, 2017
1882017
Vanillin: A comprehensive review of pharmacological activities
A Anand, R Khurana, N Wahal, S Mahajan, M Mehta, S Satija, N Sharma, ...
Plant Arch 19 (2), 1000-1004, 2019
342019
Pharmacological Management of Alzheimer’s Disease
NK Rakesh Kumar, Rajan Kumar, Abhinav Anand, Neha Sharma
Advances in Neuropharmacology Drugs and Therapeutics, 133-150, 2020
31*2020
Emerging treatments for the behavioral and psychological symptoms of dementia
A Anand, P Khurana, J Chawla, N Sharma, N Khurana
CNS spectrums 23 (6), 361-369, 2018
312018
PREDICTION OF ACTIVITY SPECTRA OF SUBSTANCES ASSISTED PREDICTION OF BIOLOGICAL ACTIVITY SPECTRA OF POTENTIAL ANTI-ALZHEIMER’S PHYTOCONSTITUENTS
A Anand, N Sharma, N Khurana
Asian Journal of Pharmaceutical and Clinical Research 10 (16), 13-21, 2017
182017
Therapeutic potential of epigallocatechin gallate
A Anand, J Chawla, A Mahajan, N Sharma, N Khurana
International Journal of Green Pharmacy (IJGP) 11 (03), 2017
152017
Prediction of anti-parkinson potential of phytoconstituents using prediction of activity spectra of substances software
R Kumar, R Kumar, A Anand, N Sharma, N Khurana
Asian Journal of Pharmaceutical and Clinical Research, 48-56, 2018
102018
The multifactorial role of vanillin in amelioration of aluminium chloride and D-galactose induced Alzheimer's disease in mice
A Anand, N Khurana, S Kaur, N Ali, AF AlAsmari, M Waseem, M Iqbal, ...
European Journal of Pharmacology 954, 175832, 2023
52023
Ameliorative effect of vanillin on scopolamine-induced dementia-like cognitive impairment in a mouse model
A Anand, N Khurana, N Ali, AF AlAsmari, M Alharbi, M Waseem, ...
Frontiers in Neuroscience 16, 1005972, 2022
52022
Food for the mind: The journey of probiotics from foods to anti-Alzheimer’s disease therapeutics
A Anand, N Khurana, R Kumar, N Sharma
Food Bioscience, 102323, 2022
22022
Amyloid beta: the foremost protagonist in alzheimer's disease
A Anand, N Sharma, M Gulati, N Khurana
Handbook of Research on Critical Examinations of Neurodegenerative Disorders …, 2019
22019
Identification of molecular targets of potential antidiabetic drugs using prediction of activity spectra for substances and molecular docking
MN Sharma
International Journal of Green Pharmacy (IJGP) 12 (02), 2018
22018
Quantification of the SARS-CoV-2 RNA in Tissues by Quantitative Real Time-PCR
A Anand, N Sharma, S Bajaj, N Wahal, D Tewari, N Khurana
Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario 1, 273, 2021
2021
THE RELATIONSHIP OF MAGNOLOL, AN IMPORTANT PHYTOCONSTITUENT, WITH NEUROLOGICAL DISORDERS: An In silico EVALUATION
A ANAND, V BABU, R GIRIYAM, S TURAN, N SHARMA, N KHURANA, ...
PLANT CELL BIOTECHNOLOGY AND MOLECULAR BIOLOGY 22 (35-36), 388-396, 2021
2021
An analysis of human immunodeficiency virus/acquired immune deficiency syndrome-related awareness among masses
A Anand, RR Patyar, SSK Dargan, S Patyar
International Journal of Basic & Clinical Pharmacology 4 (4), 678, 2015
2015
Potential of Prediction of Activity Spectra of Substances Software to Justify 3Rs
R Kumar, R Kumar, A Anand, R Mahajan, GL Khatik, N Duggal, M Mehta, ...
Evaluation of Nephroprotective Activity
K Manshare, A Anand, S Mahajan, S Satija, N Sharma, N Khurana, ...
The system can't perform the operation now. Try again later.
Articles 1–17